Clinical Trials Directory

Trials / Completed

CompletedNCT03428633

Thoracic Paravertebral Blocks in Open Nephrectomy

Thoracic Paravertebral Blocks in Open Nephrectomy. A Prospective, Randomized Study of Block Efficacy and Influence on Oxidative Stress and Patient Outcome.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Asklepieion Voulas General Hospital · Other Government
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

60 patients ASA I-III, undergoing open nephrectomy will be randomly assigned into one of two groups, namely group A (n=30), where a thoracic paravertebral block will be performed preoperatively and a paravertebral catheter for continuous and patient controlled bolus local anesthetic (ropivacaine) doses will be inserted and group B (n=30) where morphine IV will be administered at the beginning and the end of operation and postoperatively through patient controlled IV doses. NRS scores in static and dynamic conditions, complications, patient satisfaction, oxidative stress (through lactic acid, superoxide dismutase, malondialdehyde) and NGAL pre- and postoperatively, will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineParavertebral block using ropivacaine preoperatively and postoperatively
DRUGMorphineMorphine intraoperatively and postoperatively

Timeline

Start date
2018-03-09
Primary completion
2021-02-01
Completion
2023-02-01
First posted
2018-02-09
Last updated
2023-10-13

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT03428633. Inclusion in this directory is not an endorsement.